MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saitoh, T.
Right arrow Articles by Wada, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saitoh, T.
Right arrow Articles by Wada, A.

Vol. 62, Issue 4, 847-855, October 2002

Down-Regulation of Cell Surface Insulin Receptor and Insulin Receptor Substrate-1 Phosphorylation by Inhibitor of 90-kDa Heat-Shock Protein Family: Endoplasmic Reticulum Retention of Monomeric Insulin Receptor Precursor with Calnexin in Adrenal Chromaffin Cells

Tomokazu Saitoh, Toshihiko Yanagita, Seiji Shiraishi, Hiroki Yokoo, Hideyuki Kobayashi, Shin-ichi Minami, Toshio Onitsuka, and Akihiko Wada

Departments of Pharmacology (T.S., T.Y., S.S., H.Y., H.K., S.M., A.W.) and Surgery (T.S., T.O.), Miyazaki Medical College, Miyazaki, Japan

Treatment (>= 6 h) of cultured bovine adrenal chromaffin cells with geldanamycin (GA) or herbimycin A (HA), an inhibitor of the 90-kDa heat-shock protein (Hsp90) family, decreased cell surface 125I-insulin binding. The effect of GA was concentration (EC50 = 84 nM)- and time (t1/2 = 8.5 h)-dependent; GA (1 µM for 24 h) lowered the Bmax value of 125I-insulin binding by 80%, without changing the Kd value. Western blot analysis showed that GA (>= 3 h) lowered insulin receptor (IR) level by 83% (t1/2 = 7.4 h; EC50 = 74 nM), while raising IR precursor level by 100% (t1/2 = 7.9 h; EC50 = 300 nM). Pulse-label followed by reducing and nonreducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that monomeric IR precursor (~190 kDa) developed into the homodimeric IR precursor (~380 kDa) and the mature alpha 2beta 2 IR (~410 kDa) in nontreated cells, but not in GA-treated cells; in GA-treated cells, the homodimerization-incompetent form of monomeric IR precursor was degraded via endoplasmic reticulum (ER)-associated protein degradation. Immunoprecipitation followed by immunoblot analysis showed that IR precursor was associated with calnexin (CNX) to a greater extent in GA-treated cells, compared with nontreated cells. GA had no effect on IR mRNA levels and internalization rate of cell surface IRs. In GA-treated cells, insulin-induced tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) was attenuated by 77%, with no change in IRS-1 level. Thus, inhibition of the Hsp90 family by GA or HA interrupts homodimerization of monomeric IR precursor in the ER and increases retention of monomeric IR precursor with CNX; this event retards cell surface expression of IR and attenuates insulin-induced activation of IRS-1.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Immunol.Home page
V. L. Vega and A. De Maio
Increase in Phagocytosis after Geldanamycin Treatment or Heat Shock: Role of Heat Shock Proteins
J. Immunol., October 15, 2005; 175(8): 5280 - 5287.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Yokoo, T. Saitoh, S. Shiraishi, T. Yanagita, T. Sugano, S.-I. Minami, H. Kobayashi, and A. Wada
Distinct Effects of Ketone Bodies on Down-Regulation of Cell Surface Insulin Receptor and Insulin Receptor Substrate-1 Phosphorylation in Adrenal Chromaffin Cells
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 994 - 1002.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics